Skip to main content
FinSpry Logo
FinSpry
ALVO logo
ALVO
(NASDAQ)
Alvotech
$3.65-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Alvotech (ALVO) Stock Price & Financial Analysis

Alvotech Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.49 - $3.67
52-Week High$11.85
52-Week Low$3.03
Open$3.55
Volume246.83K
Average Volume (3M)246.83K
Market Cap1.10B
Shares Outstanding300.23M
P/E Ratio (TTM)15.64
Price to Sales (P/S)1.90
EV/EBITDA19.27
Revenue (TTM)570.95M
Net Income (TTM)69.50M
Free Cash Flow (TTM)-137.90M
EPS (TTM)$0.23
Profit Margin12.17%
Operating Margin7.61%
50-Day MA$4.27
200-Day MA$6.57
52-Week Change-62.45%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Alvotech

What is the current stock price for ALVO?

As of the latest trading session, ALVO stock trades at $3.65. The 52-week range is $3.03–$11.85, with a day range of $3.49–$3.67.

What is the P/E ratio for ALVO?

Alvotech's trailing P/E ratio is 15.6, meaning investors pay $15.6 for every $1 of annual earnings. Alvotech operates in the Healthcare sector.

Does ALVO pay dividends?

Alvotech does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALVO?

Based on 2 analysts, the consensus for ALVO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ALVO?

Alvotech's market capitalization is $1.10B, classifying it as a small-cap company. Alvotech operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.